|
|
Volumn 2, Issue 4 Suppl 1, 2003, Pages
|
|
Targeting BCL-2-related proteins in cancer therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
BCL2L1 PROTEIN, HUMAN;
CYTOCHROME C;
PEPTIDE;
PROTEIN BCL 2;
PROTEIN BCL X;
APOPTOSIS;
BIOLOGICAL MODEL;
CHEMICAL MODEL;
CHEMISTRY;
CLINICAL TRIAL;
HUMAN;
METABOLISM;
MITOCHONDRION;
NEOPLASM;
PATHOLOGY;
PROTEIN TERTIARY STRUCTURE;
REVIEW;
TUMOR CELL LINE;
APOPTOSIS;
BCL-X PROTEIN;
CELL LINE, TUMOR;
CLINICAL TRIALS;
CYTOCHROMES C;
HUMANS;
MITOCHONDRIA;
MODELS, BIOLOGICAL;
MODELS, CHEMICAL;
NEOPLASMS;
OLIGONUCLEOTIDES, ANTISENSE;
PEPTIDES;
PROTEIN STRUCTURE, TERTIARY;
PROTO-ONCOGENE PROTEINS C-BCL-2;
|
|
EID: 1542436707
PISSN: 15384047
EISSN: None
Source Type: Journal
DOI: 10.4161/cbt.209 Document Type: Review |
|
Times cited : (87)
|
|
References (162)
|
